Grant winners - 12 December 2013

December 12, 2013

National Institute for Health Research

Public Health Research programme

How far could widespread dissemination of parenting programmes improve child antisocial behaviour and reduce social inequalities? Combining datasets from trials in different communities to establish for whom programmes are effective

Assessing the impact and cost-effectiveness of needle/syringe provision on hepatitis C transmission among people who inject drugs: an analysis of pooled datasets and economic modelling

 

Royal Society

Wolfson Research Merit Awards

Awards are worth £10,000-£30,000 a year, which is a salary enhancement

Regulation of transcription by HDAC co-repressor complexes

Orchestron: from neuronal rhythms to rhythmic brain function

Improved indoor air quality using hygroscopic and photocatalytic materials

 

Biotechnology and Biological Sciences Research Council

Research Grants

Identifying the role of NMDA receptors in STP through investigation of synaptic plasticity and discovery of novel subtype-specific antagonists

Development of magnetometer immunoassay technology for the rapid and cost-effective detection of endemic animal diseases and pathogens (zoonoses)

Development of a point-of-need diagnostic test for infectious disease in milk

Understanding resistance and differential vaccine responses to Eimeria in the chicken – novel biomarkers and genetic control

 

Action Medical Research

Sanfilippo IIIB: developing a new gene therapy treatment for this rare and devastating disease

In detail

Anna David, University College London

Award winner: Anna David
Institution: University College London
Value: £199,962

Fetal growth restriction: investigating gene therapy

Up to 8 per cent of pregnancies develop fetal growth restriction – a serious complication that can be fatal for the unborn and cause severe complications for the survivors: the babies who make it are at higher risk of developing disabilities such as cerebral palsy and learning difficulties. This project aims to develop a treatment to tackle the complication. The research will provide important information to help in the design of large-scale tests of the treatment – planned for 2016 – for pregnant women whose babies have stopped growing properly in the womb.

Times Higher Education free 30-day trial

Please login or register to read this article

Register to continue

Get a month's unlimited access to THE content online. Just register and complete your career summary.

Registration is free and only takes a moment. Once registered you can read a total of 3 articles each month, plus:

  • Sign up for the editor's highlights
  • Receive World University Rankings news first
  • Get job alerts, shortlist jobs and save job searches
  • Participate in reader discussions and post comments
Register

Have your say

Log in or register to post comments